Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
European Urology|July 13, 2006
Radical prostatectomy in Austria: a nationwide analysis of 16,524 casesBadereddin Al-Ali Mohamad, Martin Marszalek, Clemens Brössner, et al.
Urology|November 14, 2002
Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axisStephan Madersbacher, Georg Schatzl, Christian Bieglmayer, et al.
The Journal of Urology|January 29, 2008
Outcome after radical cystectomy with limited or extended pelvic lymph node dissectionNivedita Bhatta Dhar, Eric A Klein, Alwyn M Reuther, et al.
Cancer Causes & Control : CCC|September 20, 2008
Common genetic polymorphisms of AURKA and prostate cancer riskElisabeth Feik, Andreas Baierl, Stephan Madersbacher, et al.
European Urology|July 26, 2011
Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)Altaf Mangera, Karl-Erik Andersson, Apostolos Apostolidis, et al.
Urology|October 26, 2010
Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approachMartin Marszalek, Thomas Chromecki, Badereddin Mohamad Al-Ali, et al.
BJU International|January 17, 2013
Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?Armin Henning, Marlies Wehrberger, Stephan Madersbacher, et al.
European Urology|April 14, 2009
A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostateRichard Naspro, Alexander Bachmann, Peter Gilling, et al.
Mutagenesis|February 21, 2013
MNS16A tandem repeat minisatellite of human telomerase gene and prostate cancer susceptibilityPhilipp Hofer, Julia Zerelles, Andreas Baierl, et al.
The Prostate|April 15, 2003
Reduced circulating androgen bioactivity in patients with prostate cancerTaneli Raivio, Henrikki Santti, Georg Schatzl, et al.
Pageof 18